癌症中类似干细胞CD8+T细胞
Chelsea Steiner1, Nathan Denlinger1, Xiaopei Huang1
1Division of Hematology, The Ohio State University Comprehensive Cancer Center, Columbus, OH, United States.
Frontiers in immunology
|August 30, 2024
概括
类似干 CD8+ T 细胞 (TSL) 对于持续的抗瘤免疫是至关重要的,它们来自 TCF1+ PD-1+ 细胞. 增强TSL干性为癌症免疫治疗提供了治疗潜力.
科学领域:
- 免疫学 免疫学 免疫学
- 癌症生物学 癌症生物学
- T细胞生物学T细胞生物学
背景情况:
- 类似干 CD8+ T 细胞 (TSL) 具有优越的持久性和抗瘤免疫力.
- 在免疫治疗期间,TSL细胞 (TCF1+ PD-1+) 对于瘤特异性的CD8+ T细胞扩张至关重要.
- 功能障碍的T细胞 (TLD) (TCF1-PD-1+) 在癌症等慢性疾病中来自TSL细胞.
研究的目的:
- 审查最近在癌症中TSL细胞的形成,扩张,分化和维护方面的进展.
- 探索用于治疗应用的产生TSL细胞的策略.
- 讨论在癌症治疗中增强TSL干性的临床影响.
主要方法:
- 关于癌症TSL细胞生物学最新研究的文献综述.
- 分析涉及TSL差异化和维护的不同利基.
- 讨论针对TSL细胞的潜在治疗策略.
主要成果:
- TSL细胞表现出类似干细胞的特性,并产生细胞毒性效应细胞 (TTE).
- 独特的微环境对于TSL分化和瘤的生存至关重要.
- 了解TSL生物学可以为改善癌症免疫疗法的策略提供信息.
结论:
- TSL细胞是抗瘤免疫和T细胞记忆的关键调节者.
- 准TSL细胞的生成和维护对增强癌症疗法充满希望.
- 增强TSL干细胞性可以改善疫苗设计,免疫检查点封锁和采用T细胞疗法的结果.
相关概念视频
Cancer Stem Cells and Tumor Maintenance
4.9K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
4.9K
Cytotoxic T Cells-mediated Immune Response
861
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
861
Tumor Immunotherapy
493
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
493
T Cell Activation and Clonal Selection
691
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
691
Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
T Cell Types and Functions
963
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
963


